umu.sePublications
Change search
ReferencesLink to record
Permanent link

Direct link
BALB/c mice, but not C57BL/6 mice immunized with a Delta clpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: Association of protection with post-vaccination and post-challenge immune responses
Show others and affiliations
2012 (English)In: Vaccine, ISSN 0264-410X, E-ISSN 1873-2518, Vol. 30, no 24, 3634-3645 p.Article in journal (Refereed) Published
Abstract [en]

Francisella tularensis subspecies tularensis is highly virulent for humans especially when it is inhaled. Therefore, it has the potential to be used as a biothreat agent. Vaccines against F. tularensis will need to be approved in accordance with the FDA Animal Rule. This will require identification of robust correlates of protection in experimental animals and the demonstration that similar immune responses are generated in vaccinated humans. Towards this goal, we have developed an experimental live vaccine strain by deleting the gene, clpB, encoding a heat shock protein from virulent subsp. tularensis strain, SCHU S4. SCHU S4 Delta clpB administered intradermally protects BALB/c, but not C57BL/6 mice from subsequent respiratory challenge with wildtype SCHU S4. A comparison of post-vaccination and post-challenge immune responses in these two mouse strains shows an association between several antibody and cytokine responses and protection. In particular, elevated IFN gamma levels in the skin 2 days after vaccination, sero-conversion to hypothetical membrane protein ETT_778c, and to 30S ribosomal protein Si (FTT_0183c) of F. tularensis after 30 days of vaccination, and elevated levels of pulmonary IL-17 on day 7 after respiratory challenge with SCHU S4 were all associated with protection. (C) 2012 Wayne Conlan. Published by Elsevier Ltd. All rights reserved.

Place, publisher, year, edition, pages
2012. Vol. 30, no 24, 3634-3645 p.
National Category
Microbiology in the medical area
Identifiers
URN: urn:nbn:se:umu:diva-56995DOI: 10.1016/j.vaccine.2012.03.036ISI: 000304741500020PubMedID: 22484348OAI: oai:DiVA.org:umu-56995DiVA: diva2:538933
Available from: 2012-07-02 Created: 2012-07-02 Last updated: 2016-05-24Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Sjöstedt, AndersRyden, Patrik
By organisation
Clinical BacteriologyDepartment of Mathematics and Mathematical Statistics
In the same journal
Vaccine
Microbiology in the medical area

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 87 hits
ReferencesLink to record
Permanent link

Direct link